IIM
TVTX icon

INTECH Investment Management’s Travere Therapeutics TVTX Stock Holding History

INTECH Investment Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Sell
22,541
-17,859
-44% -$534K 0.01% 1197
2025
Q4 		$1.54M Buy
40,400
+12,858
+47% +$418K 0.01% 881
2025
Q3 		$658K Sell
27,542
-11,455
-29% -$215K 0.01% 1423
2025
Q2 		$577K Sell
38,997
-14,197
-27% -$235K 0.01% 1523
2025
Q1 		$953K Buy
53,194
+20,718
+64% +$420K 0.01% 1226
2024
Q4 		$566K Buy
32,476
+12,250
+61% +$217K 0.01% 1489
2024
Q3 		$283K Buy
+20,226
New +$211K ﹤0.01% 1546

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

INTECH Investment Management's TVTX Position: Q1 2026 in Review

INTECH Investment Management reduced its Travere Therapeutics (TVTX) stake by 44% in Q1 2026, selling an estimated $534K and leaving 22,541 shares worth $670K. The position accounts for 0.01% of the portfolio, ranked #1197.

INTECH Investment Management first reported a position in TVTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.54M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • INTECH Investment Management held 22,541 shares of Travere Therapeutics worth $670K as of Q1 2026.
  • INTECH Investment Management sold 17,859 Travere Therapeutics shares in Q1 2026, an estimated $534K.
  • Travere Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q1 2026, its #1197 holding.
  • INTECH Investment Management first reported a position in Travere Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • INTECH Investment Management's Travere Therapeutics position peaked at $1.54M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.